Oral Drug Delivery Market - Forecasts from 2025 to 2030

The oral drug delivery market is forecasted to attain US$169.586 billion in 2030 at a CAGR of 4.83%, rising from US$133.944 billion in 2025.

Oral drug delivery is non-invasive, has a high rate of patient compliance, is easy to handle, and does not require any special sterile conditions; it is considered the most popular method of administration. Hence, it is highly preferred by a wide spectrum of patients. This drug delivery method is in high demand because of the prevalence of chronic diseases worldwide. Moreover, rising research and development investment, advancing health expenditure, and an aging population will all contribute to market expansion throughout the projection period.

Market Trends:

• Rise in Chronic Disease Prevalence: The global surge in chronic illnesses significantly contributes to the expansion of the oral drug delivery market. This method provides a painless and convenient option for administering medication to patients with conditions such as cardiovascular diseases, cancer, and diabetes. It also benefits from reduced oversight requirements and lower care costs. Notably, the prevalence of diabetes has spiked globally, with Diabetes UK reporting a total of 4.4 million cases in the UK alone during 2022-23, underscoring the growing demand for effective oral drug delivery solutions.
• Increased Investment in Research and Development: Advancements in drug delivery technologies, coupled with heightened R&D investments within the pharmaceutical industry, are pivotal in driving market growth.
• North America’s Market Dominance: North America is poised to capture a substantial portion of the oral drug delivery market, fueled by technological innovations, an increase in patent approvals, and pioneering research into nanotechnology applications for drug delivery. The United States, in particular, is anticipated to command a significant market share, thanks to its quick uptake of cutting-edge drug delivery technologies and the presence of research hubs focused on developing novel oral drug delivery systems throughout the forecast period.

Some of the major players covered in this report include Pfizer Inc., AstraZeneca, Alpex Pharma S.A., SPI Pharma, Globela Pharma Pvt Ltd., Lupin Pharmaceuticals, Inc., Mayne Pharma Group Limited, Adare Pharmaceuticals, Inc., AdhexPharma, Aquestive Therapeutics, RAUMEDIC, and Croda International Plc, among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What can businesses use this report for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Oral Drug Delivery Market Segmentation:

By Formulation

• Tablets
• Capsules
• Drops
• Powder
• Liquid or Syrup
• Decoction

By Application

• Disease Treatment
• Research/Academic purposes

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa